{"id":"W4403410443","doi":"10.1016/j.jtho.2024.09.013","title":"PL02.07 Neocoast-2: Efficacy and Safety of Neoadjuvant Durvalumab (D) + Novel Anticancer Agents + CT and Adjuvant D ± Novel Agents in Resectable NSCLC","year":2024,"lang":"fr","type":"article","venue":"Journal of Thoracic Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Durvalumab; Adjuvant; Oncology; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003091667,0.0003004301,0.0006052257,0.0001818696,0.0001210374,0.0004688301,0.0003107239,0.000284769,0.002177829],"category_scores_gemma":[0.0003551773,0.0001473483,0.0003278599,0.0001592799,0.0002417541,0.0004705314,0.000168989,0.0009583781,0.0003750687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005999912,"about_ca_system_score_gemma":0.0005301365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007951353,"about_ca_topic_score_gemma":0.002294568,"domain_scores_codex":[0.9999008,0.00002813614,0.000008192856,0.00002098013,0.00001400615,0.00002772681],"domain_scores_gemma":[0.9998764,0.00002412831,0.00001965683,0.00001611246,0.000006624556,0.00005702199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3128626,0.01078506,0.02137043,0.000605604,0.0009127515,0.0005150407,0.0001410847,0.003044546,0.1207473,0.0008858984,0.005846818,0.5222828],"study_design_scores_gemma":[0.1926421,0.5138032,0.1170259,0.0002568087,0.002557584,0.004853485,0.000335819,0.01850136,0.1150091,0.001270462,0.03359734,0.0001468835],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945959,0.002539161,0.0002024568,0.0002761388,0.00006578292,0.00005957427,0.000266273,0.0000533949,0.001941297],"genre_scores_gemma":[0.9965946,0.0008997009,0.0003652288,0.0002122077,0.00004563934,0.00005423203,0.0005956941,0.00001294008,0.001219716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002177829,"threshold_uncertainty_score":0.007285595,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03654236561430961,"score_gpt":0.4262339995592965,"score_spread":0.3896916339449869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}